
ARDX
NSDArdelyx Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Sunday 20th July 2025
4.41
-0.11 (-2.43%)
Prev Close:4.52
Open:4.56
Bid:4.38
Ask:4.4
52 Week Range
3.217.18
Volume:5,173,495
Mkt Cap:1,077 M
45
MarketXLS Rank ®
Hold
Price Target
$5.07
+15.0%
Financial Statements
ARDX - Cash Flow (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
---|---|---|---|---|---|---|---|---|---|---|
Capital Expenditure Reported | 344000.0 | 55000.0 | 2 M | 324000.0 | 325000.0 | 311000.0 | 2 M | 5 M | 3 M | |
Cash Flow From Continuing Investing Activities | -18 M | -131 M | 18 M | 51 M | -31 M | 23 M | -30 M | 65 M | -131 M | -3 M |
Change In Account Payable | 5 M | 279000.0 | 7 M | -1 M | 3 M | 39000.0 | -3 M | -1 M | 2 M | -371000.0 |
Change In Accrued Expense | 21 M | 4 M | 4 M | 1 M | -1000000.0 | -6 M | 1 M | 245000.0 | 8 M | 2 M |
Change In Interest Payable | -1000000.0 | -6 M | 1 M | 245000.0 | 8 M | |||||
Change In Payables And Accrued Expense | 26 M | 4 M | 11 M | 37000.0 | 2 M | -6 M | -1 M | -782000.0 | 10 M | 2 M |
Change In Prepaid Assets | -5 M | -6 M | 2 M | 502000.0 | -5 M | 93000.0 | 525000.0 | -2 M | 2 M | -4 M |
Change In Working Capital | -54 M | -35 M | -14 M | -91000.0 | -2 M | -667000.0 | 10 M | -14 M | 12 M | -47 M |
Changes In Account Receivables | -36 M | -14 M | -7 M | -502000.0 | 85000.0 | 11 M | -11 M | 3 M | ||
Depreciation And Amortization | 13 M | 9 M | 1 M | 3 M | 5 M | 3 M | 2 M | 3 M | 2 M | 1 M |
Financing Cash Flow | 107 M | 146 M | 75 M | 83 M | 23 M | 155 M | 104 M | 685000.0 | 191 M | 75 M |
Gain Loss On Investment Securities | 102000.0 | |||||||||
Gain Loss On Sale Of PPE | -1 M | 65000.0 | ||||||||
Income Tax Paid Supplemental Data | 51000.0 | 6000.0 | 4000.0 | 1000.0 | 2000.0 | 4000.0 | 3000.0 | 69000.0 | ||
Interest Paid Supplemental Data | 4 M | 3 M | 3 M | 4 M | 5 M | |||||
Issuance Of Capital Stock | 119 M | 72 M | 101 M | 21 M | 155 M | 491000.0 | 191 M | 74 M | ||
Issuance Of Debt | 22 M | -6 M | -19 M | -125000.0 | 49 M | |||||
Net Common Stock Issuance | 119 M | 72 M | 101 M | 21 M | 155 M | 491000.0 | 191 M | 74 M | ||
Net Investment Properties Purchase And Sale | 178 M | -131 M | 17 M | 53 M | -31 M | 24 M | -30 M | 68 M | -126 M | |
Net Investment Purchase And Sale | 178 M | -131 M | 17 M | 53 M | -31 M | 24 M | -30 M | 68 M | -126 M | |
Net Issuance Payments Of Debt | 22 M | -6 M | -19 M | -125000.0 | 49 M | |||||
Net Long Term Debt Issuance | 22 M | -6 M | -19 M | -125000.0 | ||||||
Net PPE Purchase And Sale | -344000.0 | 2 M | -2 M | -324000.0 | -325000.0 | -311000.0 | -2 M | -5 M | -3 M | |
Other Non-cash Items | 32 M | -3 M | 4 M | -220000.0 | 9 M | 15 M | 10 M | 10 M | 5 M | 3 M |
Pension And Employee Benefit Expense | 2 M | 5 M | 2 M | -250000.0 | 1 M | 2 M | -506000.0 | 68000.0 | 795000.0 | 718000.0 |
Proceeds From Stock Option Exercised | 1 M | 202000.0 | 1 M | 2 M | 574000.0 | 491000.0 | 685000.0 | 631000.0 | 659000.0 | |
Purchase Of Investment | -215 M | -50 M | -73 M | -151 M | -103 M | -169 M | -84 M | -134 M | ||
Purchase Of PPE | -344000.0 | -55000.0 | -2 M | -324000.0 | -325000.0 | -311000.0 | -2 M | -5 M | -3 M | |
Repayment Of Debt | -33 M | -19 M | -125000.0 | |||||||
Sale Of Investment | 178 M | 84 M | 67 M | 126 M | 120 M | 126 M | 139 M | 152 M | 8 M | |
Sale Of PPE | 2 M | |||||||||
Stock Based Compensation | 37 M | 14 M | 11 M | 12 M | 11 M | 10 M | 9 M | 10 M | 5 M | 3 M |
Amord | 11 M | 8 M | 5 M | 3 M | 313000.0 | 281000.0 | -647000.0 | 578000.0 | 454000.0 | 458000.0 |
Begcash | 91 M | 181 M | 79 M | 75 M | 75 M | 107 M | 107 M | |||
Capex | -344000.0 | 2 M | -2 M | -324000.0 | -325000.0 | -311000.0 | -2 M | -5 M | -3 M | |
Cffcf | 107 M | 146 M | 75 M | 83 M | 23 M | 155 M | 104 M | 685000.0 | 191 M | 75 M |
Cffinv | -18 M | -131 M | 18 M | 51 M | -31 M | 23 M | -30 M | 65 M | -131 M | -3 M |
Cffoa | -45 M | -90 M | -70 M | -153 M | -81 M | -76 M | -70 M | -65 M | -93 M | -72 M |
Chgcash | 43 M | -75 M | 24 M | -19 M | -90 M | 102 M | 3 M | 785000.0 | -32 M | -282000.0 |
Chginv | -42 M | -21 M | -28 M | |||||||
Chgothcl | 2 M | 3 M | 9 M | -128000.0 | 43000.0 | 5 M | 111000.0 | -47 M | ||
Chgpay | 5 M | 279000.0 | 7 M | -1 M | 3 M | 39000.0 | -3 M | -1 M | 2 M | -371000.0 |
Chgrec | -36 M | -14 M | -7 M | -502000.0 | 85000.0 | 11 M | -11 M | 3 M | ||
Comstkiss | 119 M | 72 M | 101 M | 21 M | 155 M | 491000.0 | 191 M | 74 M | ||
Depamor | 2 M | 1 M | 1 M | 3 M | 5 M | 3 M | 3 M | 3 M | 1 M | 829000.0 |
Endcash | 133 M | -75 M | 24 M | 72 M | 91 M | 181 M | 79 M | 75 M | 75 M | 107 M |
Fcf | -45 M | -90 M | -68 M | -154 M | -82 M | -77 M | -71 M | -68 M | -97 M | -75 M |
Ltdebtiss | 22 M | 27 M | ||||||||
Ltdebtpay | -33 M | -19 M | -125000.0 | |||||||
Netinccont | -39 M | -66 M | -67 M | -158 M | -94 M | -95 M | -91 M | -64 M | -112 M | -30 M |
Netothfin | 4 M | 10 M | -106000.0 | 135 M | 54 M | 30000.0 | ||||
Opcf | -45 M | -90 M | -70 M | -153 M | -81 M | -76 M | -70 M | -65 M | -93 M | -72 M |
Opgainloss | 2 M | 5 M | 866000.0 | -250000.0 | 1 M | 2 M | -506000.0 | 68000.0 | 795000.0 | 783000.0 |
Purchsti | -215 M | -50 M | -73 M | -151 M | -103 M | -169 M | -84 M | -134 M | ||
Salesti | 178 M | 84 M | 67 M | 126 M | 120 M | 126 M | 139 M | 152 M | 8 M |